Radiotheranostic Agents in Hematological Malignancies

Radioimmunotherapy (RIT) is a cancer treatment that combines radiation therapy with tumor-directed monoclonal antibodies (Abs). Although RIT had been introduced for the treatment of CD20 positive non-Hodgkin lymphoma decades ago, it never found a broad clinical application. In recent years, research...

Descripción completa

Detalles Bibliográficos
Autores principales: Caers, Jo, Duray, Elodie, Vrancken, Louise, Marcion, Guillaume, Bocuzzi, Valentina, De Veirman, Kim, Krasniqi, Ahmet, Lejeune, Margaux, Withofs, Nadia, Devoogdt, Nick, Dumoulin, Mireille, Karlström, Amelie Eriksson, D’Huyvetter, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294596/
https://www.ncbi.nlm.nih.gov/pubmed/35865548
http://dx.doi.org/10.3389/fimmu.2022.911080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294596/
https://www.ncbi.nlm.nih.gov/pubmed/35865548
http://dx.doi.org/10.3389/fimmu.2022.911080

Ejemplares similares